Article

Deep Learning Based Identification of Tissue of Origin for Carcinomas of Unknown Primary utilizing micro-RNA expression

2024-01-20

Abstract excerpt

<h4>ABSTRACT</h4> Carcinoma of Unknown Primary (CUP) is a subset of metastatic cancers in which the primary tissue source, or origin, remains unidentified. CUP accounts for three to five percent of all malignancies [2]. Representing an exceptionally aggressive category of metastatic cancers, the median survival of those diagnosed with CUP is approximately three to six months [1]. The tissue in which a cancer aris...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 90d8693e-3e4c-58e9-895f-40f4dbe00fb6
DOI: 10.1101/2024.01.17.576064

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Deep Learning Based Identification of Tissue of Origin for Carcinomas of Unknown Primary utilizing micro-RNA expressionDOI 10.1101/2024.01.17.576064Read

MicroRNA profiling for the identification of cancers with unknown primary tissue‐of‐originSemantic proximity Read

A Second-Generation MicroRNA-Based Assay for Diagnosing Tumor Tissue OriginSemantic proximity Read

CUP-AI-Dx: A tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligenceSemantic proximity Read

Molecular diagnosis and prognosis of cancers of unknown-primary (CUPs): progress from a microRNA-based droplet digital PCR assaySemantic proximity Read

Application of Transcriptome–Based Gene Set Featurization for Machine Learning Model to Predict the Origin of Metastatic CancerSemantic proximity Read

RNA-Seq Accurately Identifies Cancer Biomarker Signatures to Distinguish Tissue of OriginSemantic proximity Read

Cancer of unknown primary: the evolution of tissue of origin identification in the artificial intelligence eraSemantic proximity Read

Cancer of unknown primary.Semantic proximity Read

MicroRNA expression profiling with a droplet digital PCR assay enables molecular diagnosis and prognosis of cancers of unknown primarySemantic proximity Read

An Expression-Based Site of Origin Diagnostic Method Designed for Clinical Application to Cancer of Unknown OriginSemantic proximity Read

Validation of a transcriptome-based assay for classifying cancers of unknown primary originSemantic proximity Read

Implementation of a novel microarray‐based diagnostic test for cancer of unknown primarySemantic proximity Read